A new stem cell treatment may offer hope for Parkinson's disease. Keck Medicine of USC is investigating a unique therapy that ...
When Ron Cohen, M.D., CEO of Oryon Cell Therapies, recently dug into the company’s Parkinson’s disease data, he told Fierce ...
Oryon Cell Therapies emerged from stealth on Monday with $21 million in new funding and early clinical data showing signs ...
Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...
Brain damage caused by blocked blood vessels may be treatable using injections of stem cells, according to a new study by researchers from the University of Zurich and the University of Southern ...
A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...
Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 12 months, patients demonstrated improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results